Wolters Kluwer Health (WLSNc.D) Appoints New President & CEO For Its Medical Research Business Unit

AMSTERDAM, NETHERLANDS -- (MARKET WIRE) -- September 06, 2006 -- Wolters Kluwer Health, a division of Wolters Kluwer, and leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, announced today that it has appointed Karen Abramson President & CEO of its Medical Research business unit. The Medical Research business unit, known for its established Ovid brand, is a leading force in the development and delivery of customizable electronic research information for the medical, healthcare and academic markets.
MORE ON THIS TOPIC